Navigation Links
Thrombosis Experts Present Update on Important New Developments in Anticoagulation Management
Date:10/29/2010

the prevention and treatment of patients at risk for thrombotic and vascular disorders including atrial fibrillation, acute coronary syndromes, diabetes, cancer and transplantation associated venous occlusive disorder.  In addition, the panel considered recent worldwide regulatory developments that are changing the landscape of anticoagulation therapy which includes the introduction of newer oral anticoagulants and generic versions of branded drugs.  The symposium was very well attended and a number of the hematology professionals who attended expressed their appreciation of this timely and informative session.

Pharmaceutical Strategic Initiatives LLC (PSI) is the premier provider of strategic clinical and regulatory consulting, priority comparative effectiveness and outcomes research, scientific content creation, opinion leader development and management to Academic Institutions, Pharmaceutical, Medical Device and Biotechnology companies. For 26 years, PSI has supported Educational Programs and Workshops, Medical Affairs, Regulatory Affairs, and Medical Marketing teams by developing successful business strategies and providing the implementation skills required to produce clear, measurable outcomes.  Charles A. Carter, Pharm.D., MBA is president of Pharmaceutical Strategic Initiatives, LLC.  PSI's offices are in Research Triangle Park, North Carolina.


'/>"/>
SOURCE Pharmaceutical Strategic Initiatives LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
2. VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009
3. The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment
4. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
5. Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
6. Nanobiotechnology experts join forces to improve TB testing
7. Bait and Switch TV's Free Live Debates Invite TV Viewers to Debate with Experts in Real Time about Controversial Topics
8. Leading Cord Blood Experts Clarify Their Support of CORD:USE Family Cord Blood Bank
9. New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting
10. What's Next for Stevia? Experts from GLG Life Tech Corp Share Views on Stevia's Future at Complimentary Webinar on 17 Feb.
11. Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Chester, NJ (PRWEB) August 21, 2014 ... of personal selling optimization technology and services for ... publication of “Grading Pharma’s Use of New Commercial ... of Measurement & Analytics. , The article examines ... marketing yield that are being tested in the ...
(Date:8/21/2014)... August 21, 2014 SoundConnect ... been recognized as one of the nation’s Fastest ... magazine for the 2nd consecutive year. Inc. magazine ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ...
(Date:8/20/2014)... analysis of patented university inventions licensed to biotechnology ... to commercialization. To open these roadblocks, the researchers ... during the discovery stage could lead to faster ... frequently derived from discoveries made in university laboratories ... known during clinical trials, which have a high ...
(Date:8/20/2014)... Fla. , Aug. 20, 2014 ... will host a conference call to provide an ... 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. ... 9126599 Live web cast: www.neurotropebioscience.com , under "Investor ... hours after completion through September 2, 2014 at ...
Breaking Biology Technology:Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3Neurotrope To Host Conference Call 2
... ANGELES, March 5 Vista Partners announced today,that ... $3.52 price target on Inovio,Biomedical Corporation (Amex: ... regarding the ability of their technology to significantly,enhance ... human results,from three independent clinical studies. The company,s ...
... March 5 , - A New Step Forward ... Administration in Acute Coronary Syndrome Patients, Sanofi-aventis (EURONEXT: ... BMY ) announced today that the Committee for Medicinal,Products ... Agency,(EMEA) has issued a positive opinion recommending approval of ...
... SilOnIS shared the 2007 Jean-Pierre Noblanc ... sustainable project in the EUREKA MEDEA+,microelectronics Cluster. ... and mobile multimedia applications that makes life ... value for network operators. SilOnIS combines strained ...
Cached Biology Technology:Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target 2New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP) 2New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP) 3New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP) 4MEDEA+ Noblanc award highlights improvements in microelectronics 2MEDEA+ Noblanc award highlights improvements in microelectronics 3
(Date:8/21/2014)... in smog-producing toxins in past decade, GTA still ... shows that while the Greater Toronto Area (GTA) ... contribute to smog, the city continues to violate ... which can cause or aggravate health problems such ... by a set of complex photochemical reactions involving ...
(Date:8/21/2014)... dandruff, eczema and other itchy, flaky maladies in humans ... Hawaiian coral reefs and the extreme environments of arctic ... the scientific journal PLOS Pathogens considers the ... genus Malassezia in light of new insights ... world. , University of Hawai,i at Mānoa scientist Anthony ...
(Date:8/21/2014)... a key region in the global oceanic circulation. "On the ... Atlantic water flows to the north into the Arctic Ocean ... sea ice push their way out of the Arctic into ... cools here on its way to the north and sinks ... this manner drives the global band of oceanic currents like ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2From dandruff to deep sea vents, an ecologically hyper-diverse fungus 2Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3
... is an intimate and complex relationship between inflammation and cancer; ... chemicals that attract host cells which drive inflammation and help ... by Cell Press in the June issue of the journal ... required for trafficking of immune cells involved in inflammation. ...
... (Minority Access to Research Careers) Program has announced the ... (AAI) Advanced Course in Immunology at The University of ... 2011. These awards are meant to promote the ... the mainstream of the basic science community and to ...
... has been solved with the discovery that the tiny 3 ... use the same buoyancy control as whales. Reporting this ... from British Antarctic Survey describe how Southern Ocean copepods ... deep ocean during winter when seas are stormy and food ...
Cached Biology News:Blocking common gateway to inflammation suppresses cancer 2
... systems provide automated, higher throughput screening of ... tubes. This flexible sample format makes the ... basic research, target validation, assay development, and ... the Guava PCA-96 uses a green laser ...
... crosslinked to protein G-agarose beads which can ... heart mitochondria. Also included are 2 mg ... ,The pyruvate dehydrogenase complex (PDH) immunocapture kit ... of tissue. This facilitates the subsequent analysis ...
... into cells permits studies of protein-protein interactions, ... and transcription factor-mediated gene regulation. The most ... a specific protein in a mammalian cell ... the cell. ProteoJuice Protein Transfection Reagent is ...
... SE flow cytometry system is the superior ... over 25 years, BD cell sorters have ... in leading university, pharmaceutical, and biotechnology research ... the research demands of today, we have ...
Biology Products: